---
title: "dupilumab - Atopic dermatitis"
sidebar: mydoc_sidebar
permalink: dupilumabatopicdermatitis.html
toc: false 
---

{% include image.html url="dupilumabatopicdermatitis.png" file="dupilumabatopicdermatitis.png" alt="dupilumabatopicdermatitis" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C582203 | dupilumab | Drug |
| UniProt:P24394 | Interleukin-4 receptor subunit alpha | Protein |
| REACT:R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | Pathway |
| GO:0042092 | type 2 immune response | BiologicalProcess |
| MESH:D003876 | Atopic dermatitis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Dupilumab | DECREASES ACTIVITY OF | Interleukin-4 Receptor Subunit Alpha |
| Interleukin-4 Receptor Subunit Alpha | PARTICIPATES IN | Interleukin-4 And Interleukin-13 Signaling |
| Interleukin-4 And Interleukin-13 Signaling | POSITIVELY REGULATES | Type 2 Immune Response |
| Type 2 Immune Response | CONTRIBUTES TO | Atopic Dermatitis |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB12159#mechanism-of-action](https://go.drugbank.com/drugs/DB12159#mechanism-of-action){:target="_blank"}